Jim Buck is an inspired medical device leader who brings 30 years of experience successfully uncovering, developing and commercializing innovative medical technologies. Most recently, Jim served as the President and CEO of cancer imaging innovator ClearCut Medical while holding a Board Director position at Medcura (since 2018); was President and CEO of the American Heart Association award-winning heart valve therapy developer, Mardil Medical. Prior to that, Jim was VP of Marketing and Business Development at Closure Medical, where he directed the product-mapping strategy and execution for a novel surgical sealant and adhesive technology, that was acquired by Johnson & Johnson, for over $370 million. Jim has also worked executive and management roles for St. Jude Medical, Inc. Jim holds an MBA from Northwestern University, (Evanston, IL) and an undergraduate degree from Indiana University, (Bloomington, IN).

‍